About Alpview Capital
Alpview Capital is a venture capital firm founded in 2017. It is primarily based out of Shanghai, China. As of Jul 2022, Alpview Capital has invested in 10 companies. It primarily invests in Series B round in China based startups. Its investments are spread across a wide range of sectors from Auto Tech to High Tech and Life Sciences. Most recently it participated in the $***** Series B round of SEED Overall, Alpview Capital portfolio has seen 2 IPOs and 1 acquisition, namely WeRide, NIO and Sinopharm. A lot of funds co-invest with Alpview Capital, with names like IDG Capital sharing a substantial percentage of its portfolio. Alpview Capital has team of 8 people including 4 partners.Alpview Capital's List of Top Investments
Alpview Capital has a portfolio of 10 companies. Their most notable investments include WeRide and NIO.Their portfolio spans across China, United States and Singapore. They have invested in Auto Tech, High Tech, Life Sciences and 12 other sectors, across stages such as Series B, Series C stages. Here is the list of top investments by Alpview Capital:1. WeRide
AI-driven autonomous vehicle technologies. It provides solutions for autonomous vehicles that are enabled by both software and hardware. Real-time localization, mapping, sensor-fused perception, AI-algorithm-enabled planning, simulation test data for autonomous vehicles, and more are among the mobility solutions it provides. By combining OEM and mobility service platforms, it provides robo-taxi mobility solutions.
Key facts about WeRide
- Founded Year: 2017
- Location: San Jose (United States)
- Annual Revenue: $100M - $500M as on Dec 31, 2024
- Stage: Public
- Total Funding till date: $1.09B
- Employee Count: 573 as on Jul 31, 2026
- Investors: Deep Learning, Sailing Capital and 43 Others
- Latest Funding Round: Post IPO, Aug 15, 2025, $*****
- Highlight: Public
2. NIO
Manufacturer of electric vehicles, power solutions, and lifestyle products. The company designs and produces a range of electric sedans, SUVs, and sports cars. It also provides battery swapping services, charging solutions, and roadside assistance. Additionally, the company offers a selection of branded merchandise and accessories.
Key facts about NIO
- Founded Year: 2014
- Location: Shanghai (China)
- Stage: Public
- Total Funding till date: $1.1B
- Employee Count: 5,165 as on Jul 31, 2026
- Investors: Advantas Capital Ventures, Goldman Sachs and 75 Others
- Latest Funding Round: Post IPO, Jun 03, 2024, $*****
- Highlight: Public
3. Sinopharm
Developer of vaccines for infectious diseases. The company's lead product is the enterovirus vaccine (EV71 inactivated vaccine) to reduce the incidence of hand, foot, and mouth disease in children. It has R & D for polio vaccines, COVID-19 and pneumonia. Also, it develops in vitro diagnostic kits, medical consumables, medical protective materials, smart wearables equipment, and other product lines.
Key facts about Sinopharm
- Founded Year: 2009
- Location: Beijing (China)
- Stage: Acquired
- Employee Count: 725 as on Jul 31, 2026
- Investors: 6 Dimensions Capital, Alpview Capital and 1 Other
- Latest Funding Round: Series A, Dec 04, 2015, $*****
- Highlight: Acquired
_1560409803564.jpeg?format=webp&height=120&width=120){kind=logo}
4. VoxelCloud
VoxelCloud provides artificial intelligence based medical images and clinical data analysis platform. The platform helps in interpreting medical images and clinical data and provides doctors comprehensive diagnostic assistance. The company concentrates on lung cancer, retina diseases, and heart diseases.
Key facts about VoxelCloud
- Founded Year: 2016
- Location: Los Angeles (United States)
- Stage: Series B
- Total Funding till date: $78.5M
- Employee Count: 19 as on May 31, 2026
- Investors: Alpview Capital and Ansible Investment
- Latest Funding Round: Series B, Dec 19, 2018, $*****
Key facts about Seamless Group
- Founded Year: 2013
- Location: Singapore (Singapore)
- Stage: Series A
- Total Funding till date: $115M
- Investors: Utopian, NewMargin Ventures and 4 Others
- Latest Funding Round: Series A, Sep 11, 2017, $*****
Alpview Capital's Year-on-Year Investment Trends
Alpview Capital has invested in 10 companies over the last 5 years, with an average of 0 new investment annually in the last 5 years. Its most recent first time investment was in SEED.Alpview Capital's Investments by Stage
Alpview Capital has made 1 investment in Series B stage and 1 investment in Series C stage.Alpview Capital's Investments by Sector
Alpview Capital has a diverse portfolio, with companies operating in the Artificial Intelligence - Industry Applications, Auto Tech, High Tech and Semiconductors. Notably, it has invested in 7 Enterprise (B2B) companies, 7 Tech companies, 4 Software companies and at least 3 companies focusing on Tech hardware.Sector | No. of Investments |
|---|---|
Artificial Intelligence - Industry Applications | 1 |
Auto Tech | 1 |
High Tech | 1 |
Semiconductors | 1 |
Note: We have considered here, only first round of investments
Alpview Capital's Investments by Geography
Alpview Capital has made most investments in China (2), followed by United States where it has made 1 investment.Country | No. of Investments |
|---|---|
China | 2 |
United States | 1 |
Note: We have considered here, only first round of investments
Alpview Capital's recent investments
Alpview Capital has not made any investment in 2026 so far.Here are the most recent investments by Alpview Capital:
Filter this listDate | Company | Location | Round Details | Round Amount | Co-Investors |
|---|---|---|---|---|---|
Jul 28, 2022 | China | Series B | 9021 | ||
May 12, 2021 | United States | Series C | 7085 | [+5] |
IPOs and Publicly Listed companies in Alpview Capital's Portfolio
2 of Alpview Capital's portfolio companies have become public. WeRide got listed on the National Association of Securities Dealers Automated Quotations (NASDAQ), in Oct 2024 at marketcap of $120M and NIO got listed on the New York Stock Exchange (NYSE) at marketcap of $1B.Here are Alpview Capital's portfolio companies that went public:
Company | IPO Date | First Invested on | First Round of Investment | Round Size |
|---|---|---|---|---|
Oct 25, 2024 | May 12, 2021 | Series C | 9969 | |
Sep 12, 2018 | - | - | 6893 |
Acquired companies in Alpview Capital's Portfolio
1 company from Alpview Capital's portfolio has been acquired. The most recent acquisition was Sinopharm in Jan 2022 by Nuance Pharma for $*****.Here are Alpview Capital's portfolio companies that got acquired most recently:
Company | Acquisition Date | First Invested on | First Round of Investment | Round Size |
|---|---|---|---|---|
Jan 06, 2022 | - | - | 4023 |
Team profile of Alpview Capital
Alpview Capital has a team of 8 members including 4 Partners and 2 Principals located in China. Alpview Capital's team does not sit on the board of any company as of now.Here is a list of all team members in Alpview Capital:
Co-investors of Alpview Capital
Over the past 5 years, 28 investors have co-invested in Alpview Capital's portfolio companies. This includes funds and angels.
- Invested before Alpview Capital: Qiming Venture Partners, Johnson Electric and 15 others have invested in rounds before Alpview Capital. There is 1 company where Qiming Venture Partners has invested before Alpview Capital and 1 company where Johnson Electric has invested before Alpview Capital.
- Top Co-investors of Alpview Capital: 5 investors entered a company along with Alpview Capital. These include investors like IDG Capital (1 company).
- Invested after Alpview Capital: A total of 6 investors have invested in Alpview Capital's portfolio after their investments. Top Investors include GAC MOTOR (1 company), GAC (1 company) and Bosch (1 company).
